TABLE I.
Patient Characteristics
| DS-ALL, n (%) |
NDS-ALL, n (%) |
|
|---|---|---|
| Number | 22 | 44 |
| Gender | ||
| Male | 5 (23%) | 25 (57%) |
| Female | 17 (77%) | 19 (43%) |
| Age | ||
| 1-10 years | 20 (91%) | 37 (84%) |
| 10-18 years | 2 (9%) | 7 (16%) |
| NCI risk group | ||
| Standard | 19 (86%) | 38 (86%) |
| High | 3 (14%) | 6 (14%) |
| Ethnicity | ||
| Caucasian | 14 (64%) | 21 (48%) |
| Hispanic | 8 (36%) | 17 (39%) |
| African American | 0 (0%) | 5 (11%) |
| Asian | 0 (0%) | 1 (2%) |
| Mean BMI (kg/m2), (s.d.) | 17.1 (5.0) | 17.6 (2.9) |
| Treatment protocol | ||
| POG 9005 | 1 (5%) | 2 (5%) |
| POG 9405 | 1 (5%) | 2 (5%) |
| POG 9406 | 2 (9%) | 4 (9%) |
| POG 9905 | 11 (50%) | 22 (50%) |
| POG 9906 | 1 (4%) | 2 (4%) |
| COG AALL0331 | 6 (27%) | 12 (27%) |
DS, Down syndrome; ALL, acute lymphoblastic leukemia; NDS, non-Down syndrome; NCI, National Cancer Institute; BMI, body mass index; s.d., standard deviation; POG, Pediatric Oncology Group; COG, Children’s Oncology Group.